PDF

Download the 2018 Agenda

Download the 2018 Agenda

To view the presentations that will be delivered by our panel of senior directors, please download the event agenda.

Maximising ROI Within Clinical Trial Supply

Maximising ROI Within Clinical Trial Supply

With the help of industry experts, this Pharma IQ infographic highlights key methods to maximise returns within clinical trial supply.

Download the infographic below. 

Innovation in Clinical Trial Supply

Innovation in Clinical Trial Supply

Innovation is thought to be a keystone in the process of being competitive in any market. Within clinical trial supply, a lack of innovation can be costly in regards to a range of variables.

With this in mind, Pharma IQ discusses the latest trailblazing techniques in the arena with a panel of Clinical Trial Supply specialists.

Planning & Forecasting Considerations in Global Clinical Trial Supply

Planning & Forecasting Considerations in Global Clinical Trial Supply

Often orchestrated on a global scale, clinical trials require the production and distribution of the investigational pharmaceuticals to thousands of participants over several years. 

Here, Clinical Trial Supply Europe presents the results of its 2016 Report focused on the realms of planning and forecasting supply within global clinical trials. 

Case Study: An Inside Look Into Site Centricity

Case Study: An Inside Look Into Site Centricity

Pharma IQ speaks to Dr Samantha Carmichael, Lead Pharmacist Clinical Trials of NHS Greater  Glasgow & Clyde and Mandy Wan, Lead Paediatric Research Pharmacist, Evelina London Children’s Hospital in regards to the growing general culture of site centricity in today’s clinical trials.

Hurdling the Stumbling Blocks in Clinical Trial Supply

Hurdling the Stumbling Blocks in Clinical Trial Supply

The supply of clinical trials is the one of the most onerous tasks in this pivotal late phase of drug development. The task is further complicated by the ongoing complexity and sheer expanse of the global clinical trial supply chain. Unsurprisingly, efficiency is paramount to ensure there are no delays imposed on the drug reaching the market and, needless to say, clinical trial supply managers do not want to be the individuals responsible for jeopardising or blocking a pharmaceutical’s market access. With this in mind, Pharma IQ examines the clinical trial supply pain points and the responding technologies and tactics which have the potential to optimise current clinical trial supply practices.
Sample Delegate List - CTS

Sample Delegate List - CTS

To see a sample list of who will be attending Clinical Trial Supply Europe in January, please download the sample delegate list.